Tech
Radiolife
We are building the fire alarm for pandemics with our RF + AI technology.
Wilmington,
DE
Investment type:
Equity
(SAFE)
Target raise:
$50,000
- $107,000
Minimum investment:
$100
$100
End date:
Dec 15, 2022
Dec 15, 2022
ended
Share
Highlights
- Precise results in under 20 seconds
- ?? Patent granted – Proprietary technology based on RF signature & AI modeling
- User-friendly and Portable
- Can be remotely upgraded with new diagnostic models or for new/different diseases
Our Story
Using radiofrequency signature & AI to quickly diagnose diseases and achieving precise and accessible testing at a mass scale. RADIOLIFE developed Cube Scan, a light, user-friendly, portable & low cost device to detect, in less than 20 seconds, the presence of the Sars-Cov-2 virus in swab/saliva samples. Cube Scan uses our internationally patented technology which has 99.77% accuracy when compared to Rt-qPCR, the gold-standard method.
Our Ambition
By empowering health professionals around the World with a low cost, highly accurate mass testing device, we want to positively impact the lives of billions of people allowing a fast detection of different pathogens/diseases.